External Defibrillator Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers Global External Defibrillator Market Share and the market is segmented by Product (Manual External Defibrillator, Automated External Defibrillator (AED), and Wearable Cardioverter Defibrillator (WCD)), End User (Hospitals and Clinics, Home Care, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the value (in USD million) for the above segments.

External Defibrillator Market Size

Single User License
Team License
Corporate License
Book before:
External Defibrillator Market Summary
share button
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 7.62 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration Low

Major Players

External Defibrillator Market Major Players

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

OFF

Team License

OFF

Corporate License

OFF
Book before:

External Defibrillator Market Analysis

The external defibrillator market is expected to register a CAGR of 7.62% during the forecast period.

The COVID-19 pandemic impacted the studied market significantly. During the initial phase of the pandemic, the restriction on closures of non-essential businesses and buildings and the use and demand for automated external defibrillators (AED) accessibility decreased. According to the researchers of a study published in the Resuscitation Journal in May 2021, when all the publicly available online AED registries in Canada were analyzed for four months, 69.9% were completely inaccessible, and 18.8% were partially unavailable during the pandemic phase. As per the study above, AED accessibility reduced heavily in parks, retail and recreation locations, and workplaces during the pandemic. Thus, it affected the market studied adversely.

However, during later phases of the pandemic, following COVID-19-associated cardiovascular diseases such as myocardial injury, arrhythmias, intravascular thrombosis, and sudden cardiac death affecting the cardiovascular system, the use of external defibrillators increased. This burden of cases has increased the demand for external defibrillators as an effective intervention for cardiovascular diseases (CVDs), significantly impacting the market studied. Also, it is expected to contribute to the market growth during the forecast period.

Factors such as the increasing number of cardiac patients, rising focus by the government, and significant players toward public access defibrillators (PADs) are expected to contribute to market growth over the forecast period.

Due to the current sedentary lifestyle among the population and the growing geriatric population around the world, the burden of cardiac diseases is rising, followed by an increasing number of hospital admissions in hospitals and critical care units. A press release published by Boehringer Ingelheim GmbH in August 2021 mentioned that nearly 60 million or more people worldwide are affected by the chronic, disabling cardio-renal-metabolic illness known as heart failure. In addition, as per data released by the Australian Institute of Health and Welfare in May 2022, out of 11.8 million admissions, 7% of hospitalizations involved a stay in the intensive care Unit, and 3.8% of hospitalizations involved CVDs. Such increasing admission in emergency and critical care creates the need for the availability of cardiac rhythm management devices. Thus, this is expected to create opportunities for external defibrillators, driving the studied market growth.

Moreover, the availability of technologically advanced products in the market for patient care is further fueling the market growth. For example, in October 2021, the Welsh Rugby Union (WRU) partnered with Calon Hearts charity and Mindray distributor. With this partnership, over 300 clubs across Wales benefited from Mindray's C Series automated external defibrillators (AEDs). In addition, in April 2021, the wearable electrocardiographic defibrillator (WCD) developed by ViVest Medical was approved by the Medical Device Technology Review Center of the National Medical Products Administration to enter the special 'Review Process of Innovative Medical Devices.' It became the first made-in-China product in the external defibrillator market. These technological advancements in the external defibrillator field and the new product launches by the key market players are boosting the growth of the studied market. Thus, it is projected to witness lucrative growth during the forecast period.

However, the lack of awareness about Sudden Cardiac Arrest (SAC), stringent regulations, and frequent product recalls may restrain the growth of the external defibrillator market.

External Defibrillator Market Trends

Automated External Defibrillator (AED) is Expected to Dominate the Market in the Product Type Segment

The automated external defibrillator (AED) by product segment is expected to contribute to the growth of the external defibrillator market in the forecast period. Automated external defibrillators (AED) are mostly found in public access settings and are meant to be used by non-medical personnel. If someone suffers sudden cardiac arrest, people nearby can provide CPR and use an AED before the ambulance arrives. When turned on, the AED will give the user step-by-step directions to deliver a shock if needed. The person using the AED needs to follow the instructions and the AED will start functioning automatically. This increases the demand for the AED and accelerates the segment's growth.

AEDs majorly used in correcting patients' heartbeats through automated functions. These are easy to use for any bystanders at any place by simply following the instructions; this creates demand for the availability of automated external defibrillators in public and at home for controlling several heart conditions in an emergency.

Atrial fibrillation (A-fib) is a condition of irregular and often very rapid heart rhythm which can also lead to blood clots in the heart causing the risk of stroke, heart failure, and other heart-related complications. This is one of the most treated heart arrhythmias. As per CDC data updated in October 2022, nearly 12.1 million people in the United States are estimated to have A-fib in 2030. In addition, as per the American College of Cardiology Foundation in March 2021, public access to the AEDs has altered the survival rate of sudden cardiac arrest but nearly 70% of cardiac arrests occur at home globally. Such risk of various heart conditions among the target population creates numerous opportunities for AEDs such as at-home AEDs for controlling the risk of cardiac arrest among populations. Thereby, garnering the segment's growth.

Furthermore, product launches are majorly impacting the segment's growth, fueling the demand generation and revenue of manufacturing companies. For instance, in September 2021, ZOLL MEDICAL introduced 3 Automated External Defibrillator (AED) models to penetrate the Thailand market. This estimated that demand for AEDs in Thailand would rise to 10,000 units. In addition, in August 2021, Avive Solutions, Inc a global provider of AED, partnered with RapidSOS to provide life-saving AEDs to cardiac arrest patients in crucial times and provide telecommunicators with unprecedented occurrence data to help them more seamlessly and effectively coordinate life-saving care. Such developments are anticipated to garner segmental growth. Therefore, with the increasing burden of cardiac conditions and company activities, the segment is predicted to witness growth over the forecast period.

External Defibrillator Market - Number of People Living with Heart and circulatory diseases (in million), By Type, United Kingdom, 2021

North America Expected to Dominate the External Defibrillators Market in the Forecast Period

The North American external defibrillators (EDs) market is expected to grow during the forecast period due to the high burden and increasing prevalence of cardiovascular diseases, new product launches, and the emerging number of key market players in the United States and other countries in the region.

The high prevalence of cardiac diseases among the population in the country is expected to reap the demand for external defibrillators as these can modify the rhythm of the heart and can be lifesaving. According to 2022 statistics published by American Heart Association, the prevalence rate of heart failure in the United States was 6 million, or 1.8% of the total population, in 2021. This shows a high burden of heart failure in the country. This is increasing the need for awareness regarding technological advances, such as automatic external and wearable defibrillators. Thereby expected to fuel the market for external defibrillators growth over the forecast period in the region.

Additionally, the region has high access to external defibrillators. It has awareness about Sudden Cardiac Arrest (SAC) followed by initiatives taken by the government and private organizations for easy availability of external defibrillators. This contributes to the growth of the external defibrillators (EDs) market. For instance, In October 2021, the PulsePoint Foundation organized a PulsePoint AED Contest. In November 2021, the PulsePoint Foundation announced that Fairfield County, Ohio, won the inaugural Pulse Point AED Contest and a grant of USD 5,000 to purchase AEDs (Automated External Defibrillators) for public safety staff and the community.

In addition, the major players in the region are taking new steps in terms of partnerships, collaborations, mergers, and acquisitions to bring revolution to the market. This is driving the growth of the studied market. For instance, in September 2021, Stryker Corporation and United States Lacrosse partnered to serve as the Official AED provider for United States Lacrosse and the United States National Teams. With this partnership, United States Lacrosse members received Stryker AED devices at a discounted price. Such developments are anticipated to drive market growth in the region. Therefore, owing to all these initiatives, partnerships, and product launches, the overall market growth in the region has grown. It is expected to continue the same trend over the forecast period.

External Defibrillator Market - Growth Rate by Region

External Defibrillator Industry Overview

The external defibrillator market is fairly fragmented in terms of competition. The competitive analysis of the companies reveals that most of the companies are concentrating on new product launches and partnerships, and acquisitions for the expansion of their business. Some of the companies currently dominating the market include Asahi Kasei Corporation (Zoll Medical Corporation), Koninklijke Philips NV (Philips Healthcare), Nihon Kohden Corporation (Defibtech LLC), Schiller Americas Inc. (Schiller Ag), Shenzhen Mindray Bio-Medical Electronics Co. Ltd, Stryker, CU Medical System, Mediana Co. Ltd, BPL Medical Technologies, Heartsine Technologies Ltd, and ViVest Medical Technology Co. Ltd.

External Defibrillator Market Leaders

  1. Asahi Kasei Corporation (Zoll Medical Corporation)

  2. Koninklijke Philips N.V. (Philips Healthcare)

  3. Nihon Kohden Corporation (Defibtech LLC)

  4. Schiller Americas, inc. (Schiller Ag)

  5. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

*Disclaimer: Major Players sorted in no particular order

External Defibrillator Market Concentration
bookmark Need More Details on Market Players and Competitors?
Download PDF

External Defibrillator Market News

  • In March 2023, Safe Life acquired Coro Medical and AED.us, a national market player in Automated External Defibrillator (AED) sales and services, to Expand Life-saving Equipment and Services Across the United States.
  • In January 2023, Avive Solutions received FDA approval for its Handheld Automated External Defibrillator (AED) with unique capabilities. Avive Connect AED combines cellular and WiFi connectivity, GPS technology, remote maintenance, and extreme portability in the handheld device.

External Defibrillator Market Report - Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increase in Incidence of Cardiac Diseases

      2. 4.2.2 Availability of Technologically Advanced Defibrillators

      3. 4.2.3 Increasing Investments by Private Players

      4. 4.2.4 Rising Focus by Government and Major Players toward Public Access Defibrillator (PAD)

    3. 4.3 Market Restraints

      1. 4.3.1 Lack of Awareness about Sudden Cardiac Arrest (SAC)

      2. 4.3.2 Stringent Regulations and Frequent Product Recalls

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 5.1 By Product

      1. 5.1.1 Manual External Defibrillator

      2. 5.1.2 Automated External Defibrillator (AED)

      3. 5.1.3 Wearable Cardioverter Defibrillator (WCD)

    2. 5.2 By End User

      1. 5.2.1 Hospitals and Clinics

      2. 5.2.2 Home Care

      3. 5.2.3 Other End Users

    3. 5.3 By Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 United Kingdom

        2. 5.3.2.2 France

        3. 5.3.2.3 Germany

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 India

        2. 5.3.3.2 China

        3. 5.3.3.3 Japan

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 COMPANY PROFILES

      1. 6.1.1 Asahi Kasei Corporation (Zoll Medical Corporation)

      2. 6.1.2 Koninklijke Philips NV (Philips Healthcare)

      3. 6.1.3 Nihon Kohden Corporation (Defibtech LLC)

      4. 6.1.4 Schiller Americas Inc. (Schiller Ag)

      5. 6.1.5 Shenzhen Mindray Bio-Medical Electronics Co. Ltd

      6. 6.1.6 Stryker

      7. 6.1.7 CU Medical System

      8. 6.1.8 Mediana Co. Ltd

      9. 6.1.9 BPL Medical Technologies

      10. 6.1.10 Heartsine Technologies Ltd

      11. 6.1.11 ViVest Medical Technology Co. Ltd

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
bookmark You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

External Defibrillator Industry Segmentation

As per the scope of the report, an external defibrillator is a medical device that is designed to analyze the heart rhythm and deliver an electric shock to patients with ventricular fibrillation to restore the heart rhythm to normal. 

The External Defibrillator Market is segmented by Product (Manual External Defibrillator, Automated External Defibrillator (AED), and Wearable Cardioverter Defibrillator (WCD)), End User (Hospitals and Clinics, Home Care, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the value (in USD million) for the above segments.

By Product
Manual External Defibrillator
Automated External Defibrillator (AED)
Wearable Cardioverter Defibrillator (WCD)
By End User
Hospitals and Clinics
Home Care
Other End Users
By Geography
North America
United States
Canada
Mexico
Europe
United Kingdom
France
Germany
Italy
Spain
Rest of Europe
Asia-Pacific
India
China
Japan
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America
customize-icon Need A Different Region Or Segment?
Customize Now

External Defibrillator Market Research FAQs

The External Defibrillator Market is projected to register a CAGR of 7.62% during the forecast period (2024-2029)

Asahi Kasei Corporation (Zoll Medical Corporation), Koninklijke Philips N.V. (Philips Healthcare), Nihon Kohden Corporation (Defibtech LLC), Schiller Americas, inc. (Schiller Ag) and Shenzhen Mindray Bio-Medical Electronics Co., Ltd. are the major companies operating in the External Defibrillator Market.

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).

In 2024, the North America accounts for the largest market share in External Defibrillator Market.

The report covers the External Defibrillator Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the External Defibrillator Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

External Defibrillator Industry Report

Statistics for the 2023 External Defibrillator market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. External Defibrillator analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.

close-icon
80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!

External Defibrillator Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)